1. Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity
    Abhishek Tyagi et al, 2017, Sci Rep CrossRef
  2. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets
    Cecilia Pop-Bica et al, 2017, IJMS CrossRef
  3. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer
    Chao Li et al, 2017, Clinical Genitourinary Cancer CrossRef
  4. MicroRNA-101 downregulation increases C-Fos expression and contributes to the pathogenesis of non-small cell lung cancer
    Hai-jiang Wang et al, 2017 CrossRef
  5. MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pathway components
    Zhengzheng Su et al, 2018, Prostate CrossRef
  6. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs
    Srinivas V. Koduru et al, 2018, Sci Rep CrossRef
  7. Hsa-microRNA-101-3p expression in human urinary bladder cancer: Correlation with tumor pathology
    Yasmine A. Issa et al, 2018, Gene Reports CrossRef
  8. Novel sericin-based hepatocyte serum-free medium and sericin’s effect on hepatocyte transcriptome
    Yun Huang et al, 2018, WJG CrossRef
  9. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1
    Lin Zhu et al, 2018, CBM CrossRef
  10. MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma
    Xiaoyan Chen, 2019, Medicine CrossRef
  11. miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
    Theresa Kordaß et al, 2018, Oncotarget CrossRef
  12. 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p
    Yingyu Ma et al, 2017, Oncotarget CrossRef
  13. How microRNAs affect the PD-L1 and its synthetic pathway in cancer
    Gholamreza Rezaei Danbaran et al, 2020, International Immunopharmacology CrossRef
  14. MicroRNA‑101 inhibits cell migration and invasion in bladder cancer via targeting FZD4
    Lei Chen et al, 2018, Exp Ther Med CrossRef
  15. lncRNA TINCR facilities bladder cancer progression via regulating miR‑7 and mTOR
    Guoying Xu et al, 2020, Mol Med Rep CrossRef
  16. MicroRNAs and target molecules in bladder cancer
    Payam Kheirmand Parizi et al, 2020, Med Oncol CrossRef
  17. KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway.
    Fanchang Zeng et al, 2021, J Transl Med CrossRef
  18. Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
    Chunyu Zhang et al, 2021, Front. Oncol. CrossRef
  19. Correlation of hsa miR-101-5p and hsa miR-155-3p Expression With c-Fos in Patients of Oral Submucous Fibrosis (OSMF) and Oral Squamous Cell Carcinoma (OSCC)
    Ankita Chugh et al, 2021, J. Maxillofac. Oral Surg. CrossRef
  20. PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors
    Yang Zhao et al, 2022, CCDT CrossRef
  21. null
    Aaron Perecman et al, 2022 CrossRef
  22. NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo
    Huihui Zhang et al, 2022, BMC Urol CrossRef